Recent advances in pediatric celiac disease

References

• Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160. Epub 2011/12/27.
   PubMed Web of Science ®Google Scholar
• Dowd B, Walker-Smith J, Gee S. Aretaeus, and the coeliac affection. Br Med J. 1974;2:45–47.
   PubMed Web of Science ®Google Scholar
• Wierdsma NJ, Van bokhorst-de van der schueren MA, berkenpas M, et al. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients. 2013;5:3975–3992.
   Google Scholar
• Ludvigsson JF, Ludvigsson J, Ekbom A, et al. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care. 2006;29:2483–2488.
   PubMed Web of Science ®Google Scholar
• Elfstrom P, Montgomery SM, Kampe O, et al. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab. 2008;93:3915–3921.
   PubMed Web of Science ®Google Scholar
• Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Alimentary Pharmacology & Therapeutics. 2012;35:730–739.
   PubMed Web of Science ®Google Scholar
• Norstrom F, Sandstrom O, Lindholm L, et al. A gluten-free diet effectively reduces symptoms and health care consumption in a Swedish celiac disease population. BMC Gastroenterol. 2012;12:125.
   PubMed Web of Science ®Google Scholar
• West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. Bmj. 2004;329:716–719.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538-44;quiz 7, 45. Epub 2012/08/02.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Rubio-Tapia A, Van Dyke CT, et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol. 2013;108:818–824. Epub 2013/03/21.
   PubMed Web of Science ®Google Scholar
• Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225.
   PubMed Web of Science ®Google Scholar
• Canova C, Zabeo V, Pitter G, et al. Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy. Am J Epidemiol. 2014;180:76–85.
   PubMed Web of Science ®Google Scholar
• Verhasselt V. Neonatal tolerance under breastfeeding influence. Curr Opin Immunol. 2010;22:623–630.
   PubMed Web of Science ®Google Scholar
• Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol. 2012;2:94.
   PubMed Web of Science ®Google Scholar
• Agostoni C, Decsi T, Fewtrell M, et al. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2008;46:99–110.
   PubMed Web of Science ®Google Scholar
• Norris JM, Barriga K, Hoffenberg EJ, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. Jama. 2005;293:2343–2351.
   PubMed Web of Science ®Google Scholar
• Szajewska H, Chmielewska A, Piescik-Lech M, et al. Systematic review: early infant feeding and the prevention of coeliac disease. Aliment Pharmacol Ther. 2012;36:607–618.
   PubMed Web of Science ®Google Scholar
• Vriezinga SL, Auricchio R, Bravi E, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014;371:1304–1315.
   PubMed Web of Science ®Google Scholar
• Lionetti E, Castellaneta S, Francavilla R, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371:1295–1303.
   PubMed Web of Science ®Google Scholar
• Szajewska H, Shamir R, Chmielewska A, et al. Systematic review with meta-analysis: early infant feeding and coeliac disease–update 2015. Aliment Pharmacol Ther. 2015;41:1038–1054.
   PubMed Web of Science ®Google Scholar
• Silano M, Agostoni C, Sanz Y, et al. Infant feeding and risk of developing celiac disease: a systematic review. BMJ Open. 2016;6:e009163.
   Web of Science ®Google Scholar
• Pinto-Sanchez MI, Verdu EF, Liu E, et al. Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis. J Pediatr. 2016;168:132–43 e3.
   PubMed Web of Science ®Google Scholar
• Stordal K, White RA, Eggesbo M. Early feeding and risk of celiac disease in a prospective birth cohort. Pediatrics. 2013;132:e1202–9.
   PubMed Web of Science ®Google Scholar
• Ivarsson A, Myleus A, Norstrom F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131:e687–94.
   PubMed Web of Science ®Google Scholar
• Jansen MA, Tromp II, Kiefte-De Jong JC, et al. Infant feeding and anti-tissue transglutaminase antibody concentrations in the Generation R Study. Am J Clin Nutr. 2014;100:1095–1101.
   PubMed Web of Science ®Google Scholar
• Aronsson CA, Lee HS, Liu E, et al. Age at gluten introduction and risk of celiac disease. Pediatrics. 2015;135:239–245.
   PubMed Web of Science ®Google Scholar
• Ivarsson A, Hernell O, Stenlund H, et al. Breast-feeding protects against celiac disease. Am J Clin Nutr. 2002;75:914–921.
   PubMed Web of Science ®Google Scholar
• Szajewska H, Shamir R, Mearin L, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2016;62:507–513.
   PubMed Web of Science ®Google Scholar
• Andren Aronsson C, Lee HS, Koletzko S, et al. Effects of gluten intake on risk of celiac disease: a case-control study on a Swedish birth cohort. Clin Gastroenterol Hepatol. 2016;14:403–9 e3.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268–1273.
   PubMed Web of Science ®Google Scholar
• McLean MH, Dieguez D Jr., Miller LM, et al. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut. 2015;64:332–341.
   PubMed Web of Science ®Google Scholar
• Verdu EF, Galipeau HJ, Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;12:497–506.
   PubMed Web of Science ®Google Scholar
• Cenit MC, Olivares M, Codoner-Franch P, et al. Intestinal microbiota and celiac disease: cause, consequence or co-evolution? Nutrients. 2015;7:6900–6923.
   PubMed Web of Science ®Google Scholar
• Losurdo G, Principi M, Iannone A, et al. The interaction between celiac disease and intestinal microbiota. J Clin Gastroenterol. 2016;50(Suppl 2):S145-S147. Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S145-S7.
   PubMed Web of Science ®Google Scholar
• Sanchez E, Donat E, Ribes-Koninckx C, et al. Duodenal-mucosal bacteria associated with celiac disease in children. Appl Environ Microbiol. 2013;79:5472–5479.
   PubMed Web of Science ®Google Scholar
• De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:63.
   PubMed Web of Science ®Google Scholar
• Di Cagno R, De Angelis M, De Pasquale I, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011;11:219.
   PubMed Web of Science ®Google Scholar
• Palma GD, Capilla A, Nova E, et al. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One. 2012;7:e30791.
   PubMed Web of Science ®Google Scholar
• Olivares M, Neef A, Castillejo G, et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut. 2015;64:406–417.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Henriksen L. Cesarean section and disease associated with immune function. J Allergy Clin Immunol. 2016;137:587–590.
   PubMed Web of Science ®Google Scholar
• Namatovu F, Olsson C, Lindkvist M, et al. Maternal and perinatal conditions and the risk of developing celiac disease during childhood. BMC Pediatr. 2016;16:77.
   PubMed Web of Science ®Google Scholar
• Adlercreutz EH, Wingren CJ, Vincente RP, et al. Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease. Acta Paediatr. 2015;104:178–184.
   PubMed Web of Science ®Google Scholar
• Emilsson L, Magnus MC, Stordal K. Perinatal risk factors for development of celiac disease in children, based on the prospective Norwegian Mother and Child Cohort Study. Clin Gastroenterol Hepatol. 2015;13:921–927.
   PubMed Web of Science ®Google Scholar
• Kemppainen KM, Lynch KF, Liu E, et al. Factors that increase risk of celiac disease autoimmunity following a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2016. pii: S1542-3565(16)31043-6. doi: 10.1016/j.cgh.2016.10.033. [Epub ahead of print].
   Google Scholar
• Marild K, Kahrs CR, Tapia G, et al. Infections and risk of celiac disease in childhood: a prospective nationwide cohort study. Am J Gastroenterol. 2015;110:1475–1484.
   PubMed Web of Science ®Google Scholar
• Marild K, Ye W, Lebwohl B, et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol. 2013;13:109.
   PubMed Web of Science ®Google Scholar
• Olivares M, Castillejo G, Varea V, et al. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br J Nutr. 2014;112:30–40.
   PubMed Web of Science ®Google Scholar
• Klemenak M, Dolinsek J, Langerholc T, et al. Administration of bifidobacterium breve decreases the production of TNF-alpha in children with celiac disease. Dig Dis Sci. 2015;60:3386–3392.
   PubMed Web of Science ®Google Scholar
• Quagliariello A, Aloisio I, Bozzi Cionci N, et al. Effect of bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study. Nutrients. 2016;8:pii: E660.
   Web of Science ®Google Scholar
• Hill ID, Fasano A, Guandalini S, et al. NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders. J Pediatr Gastroenterol Nutr. 2016;63:156–165.
   PubMed Web of Science ®Google Scholar
• Alessio MG, Tonutti E, Brusca I, et al. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr. 2012;55:44–49.
   PubMed Web of Science ®Google Scholar
• Mubarak A, Wolters VM, Gerritsen SA, et al. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr. 2011;52:554–557.
   PubMed Web of Science ®Google Scholar
• Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567–573.
   PubMed Web of Science ®Google Scholar
• Klapp G, Masip E, Bolonio M, et al. Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. J Pediatr Gastroenterol Nutr. 2013;56:251–256.
   PubMed Web of Science ®Google Scholar
• Gidrewicz D, Potter K, Trevenen CL, et al. Evaluation of the ESPGHAN Celiac Guidelines in a North American pediatric population. Am J Gastroenterol. 2015;110:760–767.
   PubMed Web of Science ®Google Scholar
• Wolf J, Hasenclever D, Petroff D, et al. Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls. PLoS One. 2014;9:e97853.
   PubMed Web of Science ®Google Scholar
• Elitsur Y, Sigman T, Watkins R, et al. Tissue transglutaminase levels are not sufficient to diagnose celiac disease in North American practices without intestinal biopsies. Dig Dis Sci. 2016;62:175–179.
   PubMed Web of Science ®Google Scholar
• Trovato CM, Montuori M, Anania C, et al. Are ESPGHAN “biopsy-sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol. 2015;110:1485–1489.
   PubMed Web of Science ®Google Scholar
• Nevoral J, Kotalova R, Hradsky O, et al. Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines. Eur J Pediatr. 2014;173:497–502.
   Web of Science ®Google Scholar
• Tortora R, Imperatore N, Capone P, et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy. Aliment Pharmacol Ther. 2014;40:1223–1229.
   PubMed Web of Science ®Google Scholar
• Kurppa K, Salminiemi J, Ukkola A, et al. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr. 2012;54:387–391.
   PubMed Web of Science ®Google Scholar
• Popp A, Mihu M, Munteanu M, et al. Prospective antibody case finding of coeliac disease in type-1 diabetes children: need of biopsy revisited. Acta Paediatr. 2013;102:e102–6.
   PubMed Web of Science ®Google Scholar
• Sandstrom O, Rosen A, Lagerqvist C, et al. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing. J Pediatr Gastroenterol Nutr. 2013;57:472–476.
   PubMed Web of Science ®Google Scholar
• Webb C, Norstrom F, Myleus A, et al. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. J Pediatr Gastroenterol Nutr. 2015;60:787–791.
   PubMed Web of Science ®Google Scholar
• De Palma G, Nadal I, Collado MC, et al. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr. 2009;102:1154–1160.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105:2103–2110.
   PubMed Web of Science ®Google Scholar
• Prasad KK, Thapa BR, Nain CK, et al. The frequency of histologic lesion variability of the duodenal mucosa in children with celiac disease. World J Pediatr. 2010;6:60–64.
   PubMed Web of Science ®Google Scholar
• Arguelles-Grande C, Tennyson CA, Lewis SK, et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol. 2012;65:242–247.
   PubMed Web of Science ®Google Scholar
• Picarelli A, Borghini R, Donato G, et al. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios. Scand J Gastroenterol. 2014;49:1318–1324.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Villanacci V. Tricks of the trade: how to avoid histological pitfalls in celiac disease. Pathol Res Pract. 2012;208:197–202.
   PubMed Web of Science ®Google Scholar
• Kurppa K, Ashorn M, Iltanen S, et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr. 2010;157:373–80, 80 e1.
   PubMed Web of Science ®Google Scholar
• Schirru E, Jores RD, Congia M. Prudence is necessary in the application of the new ESPGHAN criteria for celiac disease omitting duodenal biopsy: a case report. Eur J Gastroenterol Hepatol. 2014;26:679–680.
   PubMed Web of Science ®Google Scholar
• Khatib M, Baker RD, Ly EK, et al. Presenting pattern of pediatric celiac disease. J Pediatr Gastroenterol Nutr. 2016;62:60–63.
   PubMed Web of Science ®Google Scholar
• Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527–1537.
   PubMed Web of Science ®Google Scholar
• Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100:1868–1875.
   PubMed Web of Science ®Google Scholar
• Cilleruelo ML, Fernandez-Fernandez S, Jimenez-Jimenez J, et al. Prevalence and natural history of celiac disease in a cohort of at-risk children. J Pediatr Gastroenterol Nutr. 2016;62:739–745.
   PubMedGoogle Scholar
• Elfstrom P, Granath F, Ekstrom Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst. 2011;103:436–444.
   PubMedGoogle Scholar
• Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med. 2013;159:169–175.
   PubMed Web of Science ®Google Scholar
• Smarrazzo A, Misak Z, Costa S, et al. Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective study. BMC Gastroenterol. 2017;17:17.
   PubMed Web of Science ®Google Scholar
• Egner W, Shrimpton A, Sargur R, et al. ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr. 2012;55:733–735.
   PubMed Web of Science ®Google Scholar
• Li M, Yu L, Tiberti C, et al. A report on the international transglutaminase autoantibody workshop for celiac disease. Am J Gastroenterol. 2009;104:154–163.
   PubMed Web of Science ®Google Scholar
• Vermeersch P, Geboes K, Marien G, et al. Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2013;11:398-403;quiz e32.
   PubMed Web of Science ®Google Scholar
• Guandalini S, Newland C. Can we really skip the biopsy in diagnosing symptomatic children with celiac disease. J Pediatr Gastroenterol Nutr. 2013;57:e24.
   PubMed Web of Science ®Google Scholar
• Leonard MM, Camhi S, Huedo-Medina TB, et al. Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CDGEMM) study design: approach to the future of personalized prevention of celiac disease. Nutrients. 2015;7:9325–9336.
   PubMed Web of Science ®Google Scholar
• Adriaanse MP, Leffler DA, Kelly CP, et al. Serum I-FABP detects gluten responsiveness in adult celiac disease patients on a short-term gluten challenge. Am J Gastroenterol. 2016;111:1014–1022.
   PubMed Web of Science ®Google Scholar
• Adriaanse MP, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther. 2013;37:482–490.
   PubMed Web of Science ®Google Scholar
• Moron B, Verma AK, Das P, et al. CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease. Am J Gastroenterol. 2013;108:1344–1351.
   PubMed Web of Science ®Google Scholar
• Christophersen A, Raki M, Bergseng E, et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. U Eur Gastroenterol J. 2014;2:268–278.
   PubMed Web of Science ®Google Scholar